STUDIES IN MYASTHENIA GRAVIS. PITUITARY-ADRENAL FUNCTION.
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D000311:Adrenal Glands; D000324:Adrenocorticotropic Hormone; D035843:Biomedical Research; D003401:Creatine; D003404:Creatinine; D007659:Ketones; D008797:Metyrapone; D000451:Mineralocorticoid Receptor Antagonists; D009157:Myasthenia Gravis; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors*; D010277:Parasympathomimetics; D010827:Physiology; D010900:Pituitary Diseases; D010902:Pituitary Gland; D013945:Thymoma; D014556:Urine
D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D007659:Ketones; D000451:Mineralocorticoid Receptor Antagonists; D003473:Neuromuscular Nondepolarizing Agents; D010277:Parasympathomimetics; D000324:Adrenocorticotropic Hormone; D003404:Creatinine; D003401:Creatine; D008797:Metyrapone
17-KETOSTEROIDS; ADRENAL CORTEX HORMONES; ADRENAL GLANDS; ALDOSTERONE ANTAGONISTS; CLINICAL RESEARCH; CORTICOTROPIN; CREATINE AND CREATININE; CURARIFORM ANTAGONISTS; KETONES; METYRAPONE; MYASTHENIA GRAVIS; PARASYMPATHOMIMETICS; PHYSIOLOGY; PITUITARY GLAND; THYMOMA; URINE